Rapid antibody tests have been promoted as a key tool for the world to fight the COVID-19 pandemic and get life back to normal. But this investigation by OCCRP and partners has found serious problems with the global trade in these tests.
Reporters found at least three brands of tests from the United States and European Union that are actually rebrandings of a popular Chinese test — one which independent trials have found to be less reliable than claimed.
Read the investigation:
https://www.occrp.org/en/coronavirus/uncertain-diagnosis-the-murky-global-market-for-coronavirus-antibody-tests
Uncertain Diagnosis